Clinigen

Join us at the Jefferies London Healthcare Conference from November 19-21 in London!   At Clinigen, we’re dedicated to partnering with the pharma community to bring life-changing treatments to patients around the world. Our commitment to expanding access to vital medicines drives our collaborative approach, and we’re excited to discuss how we can work together to make a global impact.   Let's connect and schedule a time to meet!   Keith Byrne, Barbara Mackey, Nihad Hasagic and Julie Gosper   #JefferiesHealthcare #Healthcareinnovation #Clinigen

At this year’s World Orphan Drug Congress Europe at the end of October, our team engaged in impactful discussions on patient access and innovation. We were honoured to have several opportunities to speak, where our experts shared specialist insights on a range of topics relating to rare diseases. Well done to Kieron Lewis, Elizabeth Taylor, Elaine Murphy, Hasan Kobat, susanne michel, Michael Epstein, Nicholas Brooke and Sheela Upadhyaya! Thank you to everyone who stopped by our booth, engaged in meaningful conversations, and shared their stories. Looking forward to the advancements we’ll make together in the year ahead! #WorldOrphanDrugCongress #RareDisease #PatientAccess #Clinigen #LifeSciences #HealthcareInnovation

Come visit the Clinigen team at Stand 69 at the World Orphan Drug Congress Europe! We're here to discuss how we can support you in bringing innovative treatments to patients in need, faster and more efficiently. Let's collaborate on solutions that make a real difference in the lives of patients with rare diseases. Stevie Dyball, Caroline O’Toole, Pamela Tulloch, Bridget Barrera, Neil Watson, Kieron Lewis, susanne michel, Nicky Edwards, Elaine Murphy, Michael Epstein, Hasan Kobat, Amy Wood, Elizabeth Taylor and Nicky Wisener #WorldOrphanDrugCongressEU #RareDiseases #ManagedAccess #Clinigen #PatientCentricity #HealthcareInnovation #ManagedAccess #EarlyAccess

Join Clinigen at BIO-Europe 2024 from 4th to 6th November in Stockholm!   Discover how Clinigen's comprehensive services can enhance access and supply for your product. Our commercial experts, Jules Shale, PhD and Pete Solman will be ready to discuss your specific needs.   Why not book a meeting with us here – https://lnkd.in/eEwYNrfY   #BIOEurope #Clinigen #Commercial #Biopharma #Inlicensing #Unlicensed #DrugDevelopment #RegulatoryAffairs #managedaccess #Pharmacovigilance

On 24th October at 11:10am, join Dr Hasan Kobat, susanne michel and Michael Epstein at the World Orphan Drug Congress Europe for their presentation session on the pivotal role of managed access programs in gathering real-world evidence to support rare disease drug development. Managed access programs provide a valuable opportunity to collect real-world data (RWD). This data can be crucial for understanding how drugs perform in real-world settings. Discover the framework for planning successful RWD collection and learn about NICE's (National Institute for Health and Care Excellence) use of RWD in appraisals. #raredisease #drugdevelopment #realworldevidence #managedaccess #HTA #pharma #wodceu

Don’t miss Elizabeth Taylor and Elaine Murphy host a roundtable discussion, on 23rd October, at 11:30am during this year’s World Orphan Drug Congress Europe. According to the European Commission, between 27 and 36 million people are affected by a rare disease. With the proposed changes in EU legislation, orphan medicines will be affected. In this working group, we will discuss the current EU legislation pertaining to orphan medicines, what's worked well and how the changes will affect stakeholders and patient access. #raredisease #wodceu #patientaccess #pharma #managedaccess

Unique challenges plague rare disease drug development. Be part of a discussion on a holistic approach integrating ESG (environmental, social, and governance) factors, patient engagement, and a winning commercial strategy to improve EU patient access. Join expert speakers Nicholas Brooke (Synergist, PFMD), Sheela Upadhyaya (Rare Disease Life Sciences Consultant) and Kieron Lewis (Clinigen) on 22nd October for their World Orphan Drug Congress Europe pre-conference workshop session at 10:30. #raredisease #drugdevelopment #patientcentric #ESG #EUaccess #pharma #wodceu

We are thrilled to be attending the World Orphan Drug Congress Europe as a Diamond Sponsor again later this month!   Barcelona is the place to be for the latest advancements in rare disease research and development. As a dedicated partner to the rare disease community, Clinigen is excited to contribute to this important event.   Our team will be at Booth No. 69 from October 22nd to 25th. We have experts from across the drug lifecycle including business development, real-world data, consulting, regulatory, market access, and operations.    Nicky Wisener, Neil Watson, Amy Wood, Nicky Edwards, Caroline O’Toole, susanne michel, Michael Epstein, Bridget Barrera, Stevie Dyball, Pamela Tulloch, Hasan Kobat, Hannah Plowman, Yazi Al'joboori, Elizabeth Taylor, Elaine Murphy and Kieron Lewis To book a meeting – https://lnkd.in/eEwYNrfY #WODCEU #managedaccess #earlyaccess #expandedaccess #compassionateuse #raredisease #orphandrugs #rwd

17- 20 October, Naples, Italy   Another exciting opportunity to connect with Clinigen’s medical and commercial teams and discover the wide range of services we offer to improve access to medicines worldwide. 🌎   Our medical experts and account managers will be on hand to introduce you to Clinigen’s expertise in providing hard-to-find medicines. Visit us at booth #9 to learn more about how we’re making a difference in access to medicines. 👉 https://lnkd.in/eEwYNrfY    SIFO Farmacia Ospedaliera #PatientCare #Clinigen #globalaccess

Did you know over 7,000 #RareDiseases affect millions globally? Unlicensed medicines (ULMs) can be a game-changer for those with rare conditions. Our SVP of Managed Access Suzanne Aitken explores the potential of ULMs and the need for a more patient-centric approach to access, in her latest article in Drug Discovery World. Read it here on page six: https://lnkd.in/e-xvXETT